ResMed Inc (RMD)
250.00
+0.44
(+0.18%)
USD |
NYSE |
Nov 26, 16:00
249.41
-0.59
(-0.24%)
After-Hours: 20:00
ResMed Cash from Financing (Quarterly): -150.76M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -150.76M |
| June 30, 2024 | -393.28M |
| March 31, 2024 | -335.91M |
| December 31, 2023 | -238.96M |
| September 30, 2023 | -151.13M |
| June 30, 2023 | -188.59M |
| March 31, 2023 | -279.56M |
| December 31, 2022 | 932.90M |
| September 30, 2022 | -41.88M |
| June 30, 2022 | 57.50M |
| March 31, 2022 | -60.86M |
| December 31, 2021 | -217.97M |
| September 30, 2021 | 92.97M |
| June 30, 2021 | -114.04M |
| March 31, 2021 | -158.54M |
| December 31, 2020 | -316.80M |
| September 30, 2020 | -175.26M |
| June 30, 2020 | -236.37M |
| March 31, 2020 | 18.39M |
| December 31, 2019 | 0.764M |
| September 30, 2019 | -100.07M |
| June 30, 2019 | -97.58M |
| March 31, 2019 | 83.18M |
| December 31, 2018 | 450.21M |
| September 30, 2018 | 144.82M |
| Date | Value |
|---|---|
| June 30, 2018 | -588.67M |
| March 31, 2018 | -276.52M |
| December 31, 2017 | -55.42M |
| September 30, 2017 | -106.08M |
| June 30, 2017 | -121.89M |
| March 31, 2017 | -52.92M |
| December 31, 2016 | -48.00M |
| September 30, 2016 | -40.05M |
| June 30, 2016 | 708.05M |
| March 31, 2016 | -16.14M |
| December 31, 2015 | -183.73M |
| September 30, 2015 | 104.41M |
| June 30, 2015 | -236.56M |
| March 31, 2015 | -26.04M |
| December 31, 2014 | 10.78M |
| September 30, 2014 | -3.965M |
| June 30, 2014 | -140.24M |
| March 31, 2014 | -144.43M |
| December 31, 2013 | -22.61M |
| September 30, 2013 | 9.96M |
| June 30, 2013 | -116.47M |
| March 31, 2013 | -30.44M |
| December 31, 2012 | -14.71M |
| September 30, 2012 | 7.69M |
| June 30, 2012 | -46.89M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-393.28M
Minimum
Jun 2024
932.90M
Maximum
Dec 2022
-97.87M
Average
-154.84M
Median
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 7.00M |
| Globus Medical Inc | 19.58M |
| Haemonetics Corp | -74.80M |
| Abbott Laboratories | -1.576B |
| Merit Medical Systems Inc | -47.57M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 325.54M |
| Cash from Investing (Quarterly) | 2.146M |
| Free Cash Flow | 1.347B |
| Free Cash Flow Per Share (Quarterly) | 2.073 |
| Free Cash Flow to Equity (Quarterly) | 335.67M |
| Free Cash Flow to Firm (Quarterly) | 307.28M |
| Free Cash Flow Yield | 3.65% |